Does renin angiotensin system blockade deserve preferred status over other anti-hypertensive medications for the treatment of people with diabetes?
1 Kaiser Permanente of Georgia and the Division of Endocrinology, Emory University School of Medicine, Atlanta, GA, USA ; 2 Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA ; 3 Department of Biostatistics, University of Texas School of Public Health, Houston, TX, USA.
Joshua I
JI
Barzilay
1 Kaiser Permanente of Georgia and the Division of Endocrinology, Emory University School of Medicine, Atlanta, GA, USA ; 2 Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA ; 3 Department of Biostatistics, University of Texas School of Public Health, Houston, TX, USA.
Paul K
PK
Whelton
1 Kaiser Permanente of Georgia and the Division of Endocrinology, Emory University School of Medicine, Atlanta, GA, USA ; 2 Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA ; 3 Department of Biostatistics, University of Texas School of Public Health, Houston, TX, USA.
Barry R
BR
Davis